Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Humana AB (publ) (HUM.ST)
Stockholm, SE
Humana AB (publ), founded in 2001 and headquartered in Stockholm, Sweden, offers a wide range of individual and family care services across Sweden, Finland, Norway, and Denmark, serving both children and adults. The company's operations are divided into five core segments. The Individual & Family segment delivers comprehensive care and treatment for individuals experiencing psychosocial disorders, mental health conditions, and functional impairments. This includes residential care homes, interim and permanent family care placements, specialized residential solutions, outpatient services, assisted living facilities, specially adapted housing for individuals with functional impairments, and special education schools. The Personal Assistance segment provides dedicated support and assistance to individuals living with functional impairments. The Elderly Care segment specializes in residential care facilities for seniors. Its Finland segment offers individual and family care services for children, young people, and families dealing with psychiatric diagnoses or psychosocial disorders, alongside specialized housing for individuals with functional impairments, and both residential and day care for seniors. Finally, the Norway segment provides individual and family care, personal assistance, and specialized housing for individuals with functional impairments.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-04 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | +1 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%-2.8% Q1'26: -2.1% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+64.8% ★ Q1'26: -44.4% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+7.4% ★ Q1'26: +2.7% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+5.2% Q1'26: +4.1% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+4.4% Q1'26: +4.2% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%-0.5% ★ Q1'26: -6.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×6.07× Q1'26: 4.41× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
Dec 2028 2 Rev. Ana. 2 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
6.36B
est: 6.36B (0.0%)
|
6.54B
est: 6.54B (+0.1%)
|
6.71B
est: 6.74B (-0.4%)
|
7.45B
est: 7.47B (-0.4%)
|
7.77B
est: 7.77B (+0.0%)
|
8.19B
est: 8.18B (+0.1%)
|
9.20B
est: 9.17B (+0.3%)
|
9.65B
est: 9.75B (-1.0%)
|
10.30B
est: 10.26B (+0.3%)
|
10.01B
est: 10.07B (-0.6%)
|
10.22B
10.07B – 10.37B
+1.4% YoY
|
10.54B
10.36B – 10.72B
+3.1% YoY
|
10.87B
10.79B – 10.95B
+3.1% YoY
|
11.46B
11.28B – 11.64B
+5.4% YoY
|
| EBITDA |
405.00M
est: 662.60M (-38.9%)
|
371.00M
est: 680.62M (-45.5%)
|
440.00M
est: 702.05M (-37.3%)
|
710.00M
est: 778.32M (-8.8%)
|
842.00M
est: 808.80M (+4.1%)
|
892.00M
est: 851.51M (+4.8%)
|
901.00M
est: 954.99M (-5.7%)
|
908.00M
est: 1.11B (-18.5%)
|
1.05B
est: 1.17B (-10.7%)
|
1.11B
est: 1.15B (-3.8%)
|
1.17B
1.15B – 1.19B
+1.4% YoY
|
1.20B
1.18B – 1.22B
+3.1% YoY
|
1.24B
1.23B – 1.25B
+3.1% YoY
|
1.31B
1.29B – 1.33B
+5.4% YoY
|
| EBIT |
356.00M
est: 333.92M (+6.6%)
|
316.00M
est: 343.00M (-7.9%)
|
377.00M
est: 353.80M (+6.6%)
|
383.00M
est: 392.24M (-2.4%)
|
473.00M
est: 407.60M (+16.0%)
|
493.00M
est: 429.12M (+14.9%)
|
440.00M
est: 481.27M (-8.6%)
|
370.00M
est: 475.45M (-22.2%)
|
465.00M
est: 500.54M (-7.1%)
|
520.00M
est: 491.40M (+5.8%)
|
498.48M
491.13M – 505.83M
+1.4% YoY
|
514.16M
505.58M – 522.74M
+3.1% YoY
|
530.27M
526.34M – 534.20M
+3.1% YoY
|
558.87M
550.07M – 567.66M
+5.4% YoY
|
| Net Income |
148.00M
est: 252.62M (-41.4%)
|
194.00M
est: 190.08M (+2.1%)
|
245.00M
est: 238.01M (+2.9%)
|
188.00M
est: 233.73M (-19.6%)
|
262.00M
est: 238.63M (+9.8%)
|
276.00M
est: 316.10M (-12.7%)
|
210.00M
est: 219.60M (-4.4%)
|
176.00M
est: 114.06M (+54.3%)
|
144.00M
est: 197.12M (-26.9%)
|
237.00M
est: 236.00M (+0.4%)
|
288.30M
271.90M – 304.70M
+22.2% YoY
|
339.13M
323.57M – 354.70M
+17.6% YoY
|
384.07M
358.86M – 409.28M
+13.3% YoY
|
339.53M
332.59M – 346.48M
-11.6% YoY
|
| SGA |
629.00M
est: 1.63B (-61.4%)
|
667.00M
est: 1.67B (-60.1%)
|
704.00M
est: 1.73B (-59.2%)
|
573.00M
est: 1.91B (-70.0%)
|
536.00M
est: 1.99B (-73.0%)
|
867.00M
est: 2.09B (-58.6%)
|
1.02B
est: 2.35B (-56.5%)
|
376.00M
est: 727.68M (-48.3%)
|
1.18B
est: 766.08M (+54.6%)
|
24.00M
est: 752.10M (-96.8%)
|
762.94M
751.69M – 774.19M
+1.4% YoY
|
786.93M
773.80M – 800.07M
+3.1% YoY
|
811.59M
805.57M – 817.61M
+3.1% YoY
|
855.36M
841.90M – 868.81M
+5.4% YoY
|
| EPS |
3.64
est: 5.04 (-27.7%)
|
3.65
est: 3.79 (-3.7%)
|
5.68
est: 4.74 (+19.7%)
|
3.54
est: 4.66 (-24.0%)
|
4.94
est: 4.76 (+3.9%)
|
5.67
est: 6.30 (-10.0%)
|
4.38
est: 4.38 (+0.1%)
|
3.68
est: 2.28 (+61.1%)
|
2.87
est: 3.95 (-27.3%)
|
4.73
est: 4.74 (-0.2%)
|
5.77
5.45 – 6.10
+21.8% YoY
|
6.79
6.48 – 7.10
+17.6% YoY
|
7.69
7.19 – 8.20
+13.3% YoY
|
6.80
6.66 – 6.94
-11.6% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-04-24 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree Europe SmallCap Dividend UCITS ETF Acc DFEA.L | 0.08% | 69.3K | 0.38% |
| 2 | WisdomTree Europe SmallCap Dividend UCITS ETF WTES.DE | 0.08% | 69.3K | 0.38% |
| 3 | WisdomTree Dynamic International SmallCap Equity ETF DDLS | 0.05% | 196.6K | 0.48% |
| 4 | WisdomTree International SmallCap Dividend Fund DLS | 0.04% | 450.2K | 0.58% |
| 5 | Dimensional - International Small Cap Value ETF DISV | 0.01% | 648.4K | 0.42% |
| 6 | State Street SPDR S&P International Small Cap ETF GWX | 0.01% | 101.6K | 0.40% |
| 7 | Dimensional - International Small Cap ETF DFIS | 0.01% | 416.2K | 0.39% |
| 8 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 386.4K | 0.22% |
| 9 | Dimensional - International Vector Equity ETF DXIV | 0.00% | 4.1K | 0.53% |
| 10 | Dimensional International Sustainability Core 1 ETF DFSI | 0.00% | 22.3K | 0.24% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Nathalie Boulas Nilsson | President, Chief Executive Officer & Country Manager for Sweden | 3M | female |
| Christoffer Herou | Chief Financial Officer | — | male |
| Ewelina Pettersson | Head of Investor Relations | — | female |
| Gabriella Reuterswardto | Chief Marketing Officer | — | female |
| Hans Dahlgren | Director of Communications, Business Area Manager of Personal Assistance & Chief Executive Officer of Humana Assistans | — | male |
| Jonas Jarborn | Chief Quality & Compliance Officer | — | male |
| Maria Jansson | Head of Sustainability & Sustainability Manager | — | — |
| Adam Nerell | Chief Information Officer | — | male |
| Nina Marklund Krantz | Director of Human Resources | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for HUM.ST
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
